title: Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery.
abstract: PCPP can be used in two different ways to potentiate an immune response. The soluble form of the polymer has been found to have immunoadjuvant activity. A single subcutaneous injection of polymer/influenza dramatically increases the ELISA, neutralizing, and HI antibodies to influenza virus compared to CFA. The polymer has also succeeded in dramatically increasing the amount of ELISA antibodies to TT. The antibody response elicited was predominantly of the IgG1 isotype. PCPP has also been used to generate micron-sized hydrogel microspheres through a process of divalent ion cross-linking of the polymer strands. These microspheres can induce significantly higher anti-TT serum IgG titers after a single intranasal immunization than TT alone.
authors.affiliation: Virus Research Institute, Inc., Cambridge, Massachusetts 02138, USA.
authors.forename: L G
authors.initials: LG
authors.lastname: Payne
authors.forename: S A
authors.initials: SA
authors.lastname: Jenkins
authors.forename: A
authors.initials: A
authors.lastname: Andrianov
authors.forename: B E
authors.initials: BE
authors.lastname: Roberts
mesh_terms: D000276:Adjuvants, Immunologic / Q000737:chemistry*; D000818:Animals; D016503:Drug Delivery Systems; D006801:Humans; D018928:Immunity, Mucosal / Q000276:immunology*; D007263:Infusions, Parenteral; D009943:Organophosphorus Compounds / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry*; D012995:Solubility; D014612:Vaccines / Q000008:administration & dosage*
chemical_list: D000276:Adjuvants, Immunologic; C070410:Ca-poly(bis(carboxylatophenoxy)phosphazene); D009943:Organophosphorus Compounds; D011108:Polymers; D014612:Vaccines